Contribution of genetic and nutritional factors to DNA damage in heavy smokers

Carcinogenesis

Volumn 18, Issue 3, 1997, Pages 503-509

  Mooney, LaVerne A ^a   Bell, Douglas A ^b   Santella, Regina M ^a   Van Bennekum, Ariette M ^c   Ottman, Ruth ^a,d   Paik, Myunghee ^a   Blaner, William S ^c   Lucier, George W ^b   Covey, Lirio ^d   Young, Tie Lan ^a   Cooper, Thomas B ^d   Glassman, Alexander H ^d   Perera, Frederica P ^a  

^a Div of Environ Health Sciences ^*  (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; DNA; GLUTATHIONE TRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON; RETINOL; TRACE ELEMENT; VALINE;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DETOXIFICATION; DNA ADDUCT; DNA DAMAGE; EXON; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUTRITION; PRIORITY JOURNAL; SMOKING; VITAMIN BLOOD LEVEL;

ADULT; BETA CAROTENE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CYTOCHROME P-450 CYP1A1; DNA DAMAGE; EXONS; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SMOKING; VITAMIN A; VITAMIN E;

EID: 0031417557     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.3.503     Document Type: Article

References (54)

1. Perera, F.P. and Mooney, L.A. (1993) The role of molecular epidemiology in cancer prevention. In DeVita, V.T., Jr, Hellman, S. and Rosenberg, S.A. (eds), Cancer Prevention. J.B. Lippincott, Philadelphi, PA, pp. 1-15.
2. Kellerman, G., Shaw, C.R. and Kellermann, M.L. (1973) Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. New Engl. J. Med., 289, 934-937.
3. Kouri, R.E., McKinney, C.E., Slomiany, D.J., Snodgrass, D.R., Wray, N.P. and McLemore, T.L. (1982) Positive correlation between high aryl hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res., 45, 5030-5037.
4. Nakachi, K., Imai, K., Hayashi, S., Watanabe, J. and Kawajiri, K. (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res., 51, 5177-5180.
5. Hayashi, S., Watanabe, J. and Kawajiri, K. (1992) High susceptibility to lung cancer analyzed in terms of combined genotype of P450IA1 and Mu-class glutathione S-transferase genes. Jpn. J. Cancer Res., 83, 866-870.
6. Crofts, F., Taioli, E., Trachman, J., Cosma, G.N., Currie, D., Toniolo, P. and Garte, S.J. (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis, 15, 2961-2963.
7. Wedlund, P.J., Kimura, S., Gonzalez, F.J. and Nebert, D.W. (1994) I462V mutation in the human CYP1A1 gene: lack of correlation with either the Msp I 1.9kb (M2) allele or Cyp1A1 inducibility in a three-generation family of East Mediterranean descent. Pharmacogenetics, 4, 21-26.
8. Cosma, G., Crofts, F., Taioli, E., Toniolo, P. and Garte, S. (1993) Relationship between genotype and function of the human CYP1A1 gene. J. Toxicol. Environ. Hlth, 40, 309-316.
9. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J. and Hayashi, S. (1993) The CYP1A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol., 14, 77-87.
10. Kawajiri, K., Nakachi, K., Imai, K., Hayashi, S. and Watanabe, J. (1990) Individual differences in lung cancer susceptibility in relation to polymorphisms of P-450IA1 gene and cigarette dose. Int. Symp. Princess Takamatsu Cancer Res. Fund, 21, 55-61.
11. Hamada., G.S. et al. (1995) The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the rsal polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol. Biomarkers Prevent., 4, 63-67.
12. Hirvonen, A., Husgafvel-Pursiainen, K., Karjalainen, A., Anttila, S. and Vainio, H. (1992) Point-mutational MspI and Ile-Val polymorphism closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol. Biomarkers Prevent., 1, 485-489.
13. Tefre, T., Ryberg, D., Haugen, A., Nebert, D.W., Skaug, V., Brogger, A. and Borresen, A. (1991) Human CYP1A1 (cytochrome P450) gene: lack of association between the Mspl restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics, 1, 20-25.
14. Shields, P.G., Caporaso, N.E., Falk, R.T., Sugimura, H., Trivers, G.E., Trump, B.F., Hoover, R.N., Weston, A. and Harris, C.C. (1993) Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol. Biomarkers Prevent., 2, 481-485.
15. Seidegard, J., Pero, R.W., Markowitz, M.M., Roush, G., Miller, D.G. and Beattie, E.J. (1990) Isoenzyme(s) of glutathione transferase (class mu) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis, 11, 33-36.
16. Zhong, S., Howie, A.F., Ketterer, B., Taylor, J., Hayes, J.D., Beckett, G.J., Wathen, C.G., Wolf, C.R. and Spurr, N.K. (1991) Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis, 9, 1533-1537.
17. Alexandrie, A.K., Sundberg, M.I., Seidegard, J., Tornling, G. and Rannug, A. (1994) Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis, 15, 1785-1790.
18. Bell, D.A., Thompson, C.L., Taylor, J., Clark, G., Miller, C.R., Perera, F., Hsieh, L. and Lucier, G.W. (1992) Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase. Environ. Hlth Perspect., 98, 113-117.
19. Ketterer, B. (1988) Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat. Res., 202, 343-361.
20. Block, G. (1992) The data support a role for antioxidants in reducing cancer risk. Nutr. Rev., 50, 207-213.
21. Carpenter, M.P. (1991) Vitamins and cancer prevention. In Contemporary Issues in Clinical Nutrition: Vitamins and Cancer Prevention. Wiley-Liss, New York, NY, pp. 61-90.
22. Knekt, P. (1993) Vitamin E and smoking and the risk of lung cancer. Annls NY Acad. Sci., 686, 280-288.
23. Byers, T. (1994) Diet as a factor in the etiology and prevention of lung cancer. In Samet, J.M. (ed.), Epidemiology of Lung Cancer. Marcel Dekker, New York, NY, pp. 335-352.
24. Willett, W.C. (1994) Micronutrients and cancer risk. Am. J. Clin. Nutr., 59 (suppl.), 1162S-1165S.
25. Grinberg Funes, R.A., Singh, V.N., Perera, F.P., Bell, D.A., Young, T.L., Dickey, C., Wang, L.W. and Santella, R.M. (1994) Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and glutathione S-transferase M1 genotype. Carcinogenesis, 15, 2449-2454.
26. Perera, F.P. et al. (1994) Carcinogen-DNA adducts and gene mutation in foundry workers with low level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis, 15, 2905-2910.
27. Perera, F.P. et al. (1992) Molecular and genetic damage from environmental pollution in Poland. Nature, 360, 256-258.
28. Mooney, L.A. et al. (1995) Decline in DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol. Biomarkers Prevent., 4, 627-634.
29. Tang, D. et al. (1995) A case-control molecular epidemiologic study of lung cancer. Cancer Epidemiol. Biomarkers Prevent., 4, 341-346.
30. Bjorkquist, S.E. (1975) Clonidine in alcohol withdrawal. Acta Paediat. Scand., 52, 256-263.
31. Gold, M.S., Redmond, D.E. and Kleber, H.D. (1978) Clonidine in opiate withdrawal. Lancet, i, 929-930.
32. Glassman, A.H., Jackson, W.K. and Walsh, B.T. (1984) Cigarette craving, smoking withdrawl, and clonidine. Science, 226, 864-866.
33. Perera, F.P., Hemminki, K., Young, T.L., Brenner, D., Kelly, G. and Santella, R.M. (1988) Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. Cancer Res., 48, 2288-2291.
34. Davis, R.A. (1986) The determination of nicotine and cotinine in plasma. J. Chromatogr. Sci., 24, 134-141.
35. O'Neill, I.K., Brunnemann, K.D., Dodet, B. and Hoffmann, D. (1987) Environmental Carcinogens: Methods of Analysis and Exposure Measurement, IARC Scientific Publication no. 81. International Agency for Research on Cancer, Lyon, France, pp. 3-5.
36. Bell, D.A., Taylor, J.A., Paulson, D.F., Robertson, C.N., Mohler, J.L. and Lucier, G.W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl Cancer Inst., 85, 1159-1164.
37. Mills, J.L. et al. (1992) Maternal vitamin levels during pregnancies producing infants with neural tube defects. J. Pediat., 120, 863-871.
38. Denissenko, M.F., Pao, A., Tang, M. and Pfeifer, G.P. (1996) Preferential formation of benzo(a)pyrene adducts at lung cancer mutational hotspots in P53. Science, 274, 430-432.
39. Niki, E., Noguchi, N., Tsuchihashi, H. and Gotoh, N. (1995) Interaction among vitamin C, vitamin E, and β-carotene. Am. J. Clin. Nutr., 62, 1322S-1326S.
40. McWilliams, J.E., Sanderson, B.J.S., Harris, E.L., Richert-Boe, K.E. and Henner, W.D. (1995) Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol. Biomarkers Prevent., 4, 589-594.
41. Shah, G.M. and Bhattacharya, R.K. (1980) Inhibition by L-ascorbate of binding to DNA or BaP and its metabolites. Ind. J. Biochem. Biophys., 17, 96-98.
42. Kallistratos, G. and Fasske, E. (1980) Inhibition of benzo(a)pyrene carcinogenesis in rats with vitamin C. J. Cancer Res. Clin. Oncol., 97, 91-96.
43. Chen, L.H. and Chih-Chii, A.S. (1989) Induction of glutathione-S-transferase activity by antioxidants in hepatocyte culture. Anticancer Res., 9, 1069-1072.
44. Combs, G.F., Jr (1992) The Vitamins: Fundamental Aspects in Nutrition and Health. Academic Press, New York, NY.
45. Gudas, L.J., Sporn, M.B. and Roberts, A.B. (1994) Cellular biology and biochemistry of the retinoids. In Sporn, M.B., Roberts, A.B. and Goodman, D.S. (eds), The Retinoids, Biology, Chemistry, and Medicine, 2nd Edn. Raven Press, New York, NY, pp. 443-520.
46. Mangelsdorf, D.J., Umesono, K. and Evans, R.M. (1994) The retinoid receptors. In Sporn, M.B., Roberts, A.B. and Goodman, D.S. (eds), The Retinoids, Biology, Chemistry, and Medicine, 2nd Edn. Raven Press, New York, NY, pp. 319-350.
47. Kato, S., Bowman, E.D., Harrington, A.M., Blomeke, B. and Shields, P.G. (1995) Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. JNCI, 87, 902-907.
48. Yang, C.S., Brady, J.F. and Hong, J.Y. (1992) Dietary effects on cytochromes P450, xenobiotic metabolism, and toxicity. FASEB J., 6, 737-744.
49. Livrea, M.A. and Packer, L. (1994) Vitamin A as an antioxidant in vitro and in vivo. In Livrea, M.A. and Packer, L. (eds), Retinoids: From Basic Science to Clinical Applications. Birkhauser Verlag, Basel, Switzerland, pp. 293-304.
50. Shields, P.G., Bowman, E.D., Harrington, A.M., Doan, V.T. and Weston, A. (1993) Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res., 53, 3486-3492.
51. Rothman, N., Shields, P.G., Poirier, M.C., Harrington, A.M., Ford, D.P. and Strickland, P.T. (1995) The impact of glutathione S-transferase M1 and cytochrome P450 1A1 genotypes on white blood cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans. Mol. Carcinogen., 14, 63-68.
52. Ichiba, M., Hagmar, L., Rannug, A., Högstedt, B., Alexandrie, A.K., Carstensen, U. and Hemminki, K. (1994) Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST in chimney sweeps. Carcinogenesis, 15, 1347-1352.
53. Duthie, S.J., Ma, A., Ross, M.A. and Collins, A.R. (1996) Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res., 56, 1291-1295.
54. Alpha-Tocopherol BCCPSG (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New Engl. J. Med., 330, 1029-1035.